Ecovyst Q4 net loss $30.5M on $65M impairment; guides 2025 sales $755-815M

Ecovyst Inc.

2024-FY EPS reported -$0.06 revenue$704,493,000

Q4 net loss $30.5M (diluted loss $0.26) vs net income $30M a year ago; includes $65M non-cash impairment on Zeolyst JV.
Full year sales $704.5M (+2% YoY); adjusted EBITDA $238.2M (29.0% margin).
2025 guidance: sales $755-815M, adj. EBITDA $238-258M, adj. diluted EPS $0.50-0.70.
Strategic review of Advanced Materials & Catalysts segment underway, expected completion mid-2025.
Net debt leverage 3.0x; $229.6M remaining in share repurchase authorization.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001708035-25-000063
form_type: 8-K
ticker: ECVT
cik: 0001708035
company_name: Ecovyst Inc.
filed_at: 2025-02-27T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.523647+00:00
generated_at: 2026-05-26T02:14:37.764640+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: negative
materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001708035-25-000063
json_url: https://secwatch.observer/filing/0001708035-25-000063.json
markdown_url: https://secwatch.observer/filing/0001708035-25-000063.md
text_url: https://secwatch.observer/filing/0001708035-25-000063.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1708035/000170803525000063/0001708035-25-000063-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1708035/000170803525000063/ecvt-20250227.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001708035-25-000063

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.